Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-093872
Filing Date
2025-07-03
Accepted
2025-07-03 16:16:04
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3986
  Complete submission text file 0000950170-25-093872.txt   5592
Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104
Business Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 L2 D01 H104 (872) 225-6077
Iterum Therapeutics plc (Issuer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3 DUBLIN LANDINGS NORTH WALL QUAY DUBLIN 1 Ireland D01 C4E0
Business Address
Coyne Christine (Reporting) CIK: 0001861840 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38503 | Film No.: 251105759